Status:
COMPLETED
Evaluation of Deployment Capability and Accuracy of an Outside the Scope (OTS), Detachable Catheter System for Ablation of Peripheral Lung Lesions: An Ex-Vivo Human Lung Model Study
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Lung Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
A novel OTS detachable probe system carried outside and along the flexible bronchoscope has been developed. Using this novel system, the operator can deploy the probe in the target bronchus and lesion...
Detailed Description
Lung ablative therapies have growing interest in the treatment of early-stage primary lung cancer in surgical high-risk patients and as part of multimodal treatment in patients with large lesions or m...
Eligibility Criteria
Inclusion
- Patients who follow surgery for the removal of diseased lungs before being submitted to a bilateral lung transplant.
Exclusion
- None
Key Trial Info
Start Date :
October 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2023
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04722432
Start Date
October 16 2020
End Date
September 21 2023
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUM
Montreal, Quebec, Canada